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Abstract 
Objective: The objective of this study is to determine if a model for patient-centered care that integrates medication management 
between hospital and community pharmacists is feasible and can improve medication adherence. Design: This was a randomized, non-
blinded, interventional study of 69 patients discharged from a hospital to home. Process measures include the number and type of 
medication-related discrepancies or problems identified, patient willingness to participate, the quality and quantity of interactions with 
community pharmacists, hospital readmissions, and medication adherence. Setting: A 214-bed acute care hospital in Northeastern 
Pennsylvania and seventeen regional community pharmacies. Patients: Enrolled patients were hospitalized with a primary or secondary 
diagnosis of heart failure or COPD, had a planned discharge to home, and agreed to speak to one of seventeen community pharmacists 
within the study network (i.e., a network community pharmacist) following hospital discharge. Intervention: Information about a 
comprehensive medication review completed by the hospital pharmacist was communicated with the network community pharmacist 
to assist with providing medication therapy management following hospital discharge. Results: Of 180 patients eligible for the study, 
111 declined to participate. Many patients were reluctant to talk to an additional pharmacist, however if the patient’s pharmacist was 
already within the network of 17 pharmacies, they usually agreed to participate. The study enrolled 35 patients in the intervention 
group and 34 in the control group. An average of 6 medication-related problems per patient were communicated to the patient’s 
network community pharmacist after discharge. In the treatment group, 44% of patients had at least one conversation with the 
network community pharmacist following hospital discharge. There was no difference in post-discharge adherence between the groups 
(Proportion of Days Covered 0.76 treatment group vs. 0.73 control group, p=0.69), but there was a reduction in hospital readmissions 
(43% treatment group vs. 62% control group). Conclusion: The feasibility of this model can be improved by integrating medication 
management with the patient’s existing community pharmacist, rather than an additional network community pharmacist. While there 
was no difference in medication adherence, collaboration between the hospital and community pharmacists can potentially reduce 
hospital readmissions, improve medication safety, and facilitate medication therapy management across care transitions. 
 




The transition of care from hospital to home is susceptible to 
a lack of coordination and continuity especially related to 
medication management.  This is particularly problematic for 
patients with comorbidities such as heart failure and chronic 
obstructive pulmonary disease (COPD) where medication 
management is essential for improved health outcomes.  Heart 
failure medications known to improve mortality are under-
prescribed with less than 60% of eligible Medicare patients 
prescribed an angiotensin converting enzyme inhibitor (ACEI) 
or angiotensin receptor blocker (ARB) and less than 40% 
prescribed a beta-blocker.1,2  Similarly, about half of patients 
diagnosed with COPD are not receiving evidence-based 
treatment despite evidence of reduced hospitalization and 
healthcare costs.3,4   This presents an opportunity for 
pharmacists to promote the appropriate use of medications 
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Medication non-adherence is one factor that can contribute to 
the need for a transition to a higher intensity of care.  
Adherence to medications is poor; it is estimated that 
approximately half of medications for chronic disease are not 
taken as prescribed.5,6  Non-adherence is related to increased 
hospitalization, morbidity, and mortality7,8 and is estimated to 
cause at least half of all medication-related hospital 
admissions.9    There are several complex reasons for non-
adherence including cost, forgetfulness, complexity of the 
regimen, adverse effects, health literacy, emotional factors,  
and the patient’s own understanding of the risks and benefits 
of the medication.9  Improved medication adherence can 
improve patient outcomes and reduce unnecessary healthcare 
spending.1,3,4,10  A model that facilitates the patient-pharmacist 
relationship could identify  and address factors leading  to non-
adherence.     
 
Two additional factors contributing to worse outcomes during 
transitions of care are a lack of communication and inadequate 
patient education.11  Communication and collaboration 
between inpatient and outpatient healthcare providers during 
care transitions is often lacking, leading to fragmented patient 
care.  Patient education about medications on the day of 
discharge is often rushed and overwhelming for the patient.  In 
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many cases, this lack of coordination between the hospital and 
community settings as well as the rushed environment on the 
day of discharge results in patients that are not prepared to 
manage their medications once transitioned to home.   Most 
transitional care programs are primarily limited to inpatient 
settings, have a short duration (e.g., less than 1 month), and 
target short term outcomes such as 30-day readmissions.  A 
potent stimulus for reducing 30-day readmission stems from a 
financial penalties for hospitals with high readmission rates.  A 
disadvantage of programs that primarily target this outcome is 
that they may only delay rather than reduce hospitalization.  
 
The Care Transitions Intervention is one strategy that has been 
shown to consistently reduce 30-day hospital readmissions by 
about 30% in several settings.11-13  In this intervention, patients 
at high risk of readmissions are assigned a dedicated transition 
provider, usually with a background in nursing or social work, 
who coaches patients to take a more active role in their 
healthcare and communicate effectively with their providers.  
The interventions occur within 30 days following hospital 
admission and include a hospital visit, home visit, and 2 follow-
up telephone calls.  This model encourages patients to keep an 
accurate health and medication history, and communicate 
their concerns with their providers.  Based on evidence 
showing a reduction in hospital readmissions, many healthcare 
systems and physician groups have incorporated a care-
transition manager to target patients at increased risk of 
readmissions.  While this program provides meaningful face-
to-face interactions and has evidence of reducing 30-day 
readmissions, it does not insure comprehensive medication 
management during care transitions.  
 
Two other projects have shown a reduction in hospital 
utilization through improved transitional care models.  The 
Reengineered Hospital Discharge (RED) model incorporates 
nurse discharge advocates that coordinate the discharge plan, 
medications, and any patient education related to 
medications.14  A hospital pharmacist speaks to the patient by 
phone within 2 days of discharge.  While this model has been 
shown to reduce hospital utilization by 30% and healthcare 
spending, a more longitudinal approach to medication 
management across the care transition may improve 
outcomes further.  Another transitional care model using 
advanced practice nurses to complete discharge planning and 
frequent home follow-up visits for a 3-month period has been 
shown to reduce hospital readmissions and healthcare costs.15  
It is widely recognized that inter-professional collaboration is 
an important factor in the quality of care provided.  Therefore 
programs that facilitate collaboration between healthcare 
providers during hospitalization as well as following hospital 
discharge could further improve patient outcomes at a 
reduced cost.  
 
An accurate medication list is necessary for effective 
coordination of care across transitions.  While hospitals 
routinely complete medication reconciliation on all patients, 
that information is often inaccurate and rarely shared beyond 
the hospital system. The goal of medication reconciliation is to 
“obtain and maintain accurate and complete medication 
information for a patient and use this information within and 
across the continuum of care to ensure safe and effective 
medication use.”16  Errors that occur during the admission 
medication reconciliation  can contribute  to medication errors 
during  hospitalization and at discharge.  It is estimated that 
60% of medication errors occur during care transitions.  
Subsequently, medication errors are associated with 
approximately 1.5 million preventable adverse drug events 
annually.17   Communicating accurate information about 
medication reconciliation to the patient’s community 
pharmacist is an effort to improve medication management 
across care transitions.  Facilitating the community 
pharmacist’s role in preventing medication-related problems 
that commonly occur during the transition from hospital to 
home can improve the quality of care.   
 
The quality of healthcare during care transitions has significant 
room for improvement and community pharmacists are 
uniquely positioned to collaborate with other practitioners 
and provide patient and caregiver education to improve 
medication management.  Pharmacists can improve the 
transition of care by preventing medication-related problems, 
encouraging the appropriate use of medications, and 
facilitating communication with other healthcare providers.  
Pharmacists can educate patients and caregivers about their 
medications, healthy lifestyles, recommended self-care, and 
disease state management.  This can only happen, however if 
the community pharmacists have current information about 
their patients such as medication indications and reasons for 
any medication changes at hospital discharge.  We hypothesize 
that communication between the hospital and community 
pharmacist can prevent medication-related problems 
including non-adherence in patients at increased risk for 
medication-related problems and hospitalization.  This 
approach would facilitate comprehensive medication 
management across care transitions.  Patients with heart 
failure and COPD are being targeted for medication 
management during the transition of care from hospital to 
home because they require multiple medications, are at 
increased risk of hospitalization, and usually have modifiable 
risk factors.18,19    Through their relationship with patients, 
community pharmacists have the potential to provide 
medication management on a regular and long-term basis and 
collaborate with the patient’s other healthcare providers to 
prevent medication-related problems. Our goal is to improve 
the community pharmacist’s role in identifying and preventing 
medication-related problems that commonly occur during the 
transition from hospital to home in patients with heart failure 
or COPD.   
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Objectives 
The objective of this pilot study was to assess the feasibility of 
an innovative pharmacy practice model that integrates 
medication therapy management between hospital and 
community pharmacists during the transition from hospital to 
home and determine if this model improves medication 
adherence.    
 
Methods 
This was a randomized non-blinded interventional study of 
patients admitted to Moses Taylor Hospital with a primary or 
secondary diagnosis of heart failure or COPD and had a 
planned discharge to home.  Exclusion criteria included the 
presence of cognitive impairment that prevented effective 
patient education and counseling.  Other exclusion criteria 
were non-English-speaking patients, those with anticipated 
discharge to a long-term care or skilled nursing facility, 
patients admitted for elective surgery, and hospice patients.    
 
Eligible patients were randomized into a treatment and control 
group. Sequentially numbered, opaque, sealed envelopes 
were used to allocate the treatment and control groups and 
each envelope contained a random assignment to either 
group.  Patients agreeing to participate signed an 
authorization for the release of health information and an 
informed consent.   The study procedures were followed in 
accord with the ethical standards of the institutional 
investigational review board.   
 
A network of seventeen community pharmacies located 
throughout the region agreed to participate in this study.  
Hospital and community pharmacists who participated in the 
study completed an 8-hour training program designed by 
pharmacy faculty at Wilkes University.  This included recorded 
online learning as well as face-to-face programming.  Topics 
covered included disease state management, medication 
reconciliation, motivational interviewing, and approaches to 
patient-centered care.     
 
Patients were enrolled from January 2014 through October 
2014.  Prior to randomization, a pharmacist collected data 
about eligible patients from the electronic health record in 
preparation for meeting with the patients.  Each meeting  
between the hospital pharmacist and  patient lasted for an 
average of 10-20 minutes and was focused on verifying the 
medication reconciliation completed during hospital 
admission, assessing the patient’s understanding of their 
home medications, determining the patient’s preferences, 
goals and concerns, and identifying any actual or potential 
medication-related problems through a comprehensive 
medication review.  During verification of the medication 
reconciliation, the pharmacist identified and corrected errors 
from the admission medication reconciliation that had been 
completed usually by a nurse or physician.  While it is not 
standard of care for a pharmacist to meet with each patient in 
the hospital, for the  purpose of this study, a pharmacist met 
with patients who were eligible for this study.  In reviewing the 
patient’s electronic health record and meeting with the 
patient, if a medication-related problem was identified that 
required immediate attention, the pharmacist would work to 
resolve the problem regardless of study enrollment or study 
group assignment.  Acute care issues were discussed with the 
inpatient prescribers and issues related to chronic medications 
were discussed with the patient’s primary care physician.         
    
Patients randomized into the intervention group chose from a 
list of network community pharmacies where they would meet 
with a pharmacist in person or by phone to discuss their 
medications on a monthly basis for six months.  Patients were 
not required to obtain their prescription medications from the 
network pharmacies.  The network community pharmacists 
received a written summary from the hospital pharmacist of 
medication management that included the reconciled 
medication list at discharge, reasons for medication changes at 
discharge, medication indications, and suggested clinical 
issues and patient education for follow-up.  In addition, a 
phone conversation between the hospital and community 
pharmacist occurred prior to the community pharmacist’s first 
meeting with the patient to discuss an overview of the patient 
and any medication-related problems.  The network 
community pharmacist was then asked to provide medication 
therapy management including patient counseling and 
education monthly for six months following hospital discharge. 
Using the summary of medication management provided by 
the hospital pharmacist, the community pharmacist had more 
context than they normally have to assess the safety and 
efficacy of medications and identify opportunities for 
improvement.  This could include but is not limited to issues 
related to evidence-based disease-state management, 
medication monitoring, and follow-up on patient education 
that had been discussed during hospitalization.  The 
community pharmacists were also encouraged to discuss 
issues with the patient’s primary care provider if needed to 
resolve medication-related problems.  The pharmacies were 
compensated for the clinical service provided to each patient. 
The primary care physician also received a faxed summary 
from the hospital pharmacist of medication-related problems 
and recommendations.   
 
Patients in the control group received no additional 
communication between the hospital and community 
pharmacist besides the standard of care.  For example, if 
clarification was needed on a home medication, the hospital 
pharmacist would contact the community pharmacist.  
However, for the control group there was no written or verbal 
summary of medication management developed for the 
community pharmacist. The patients were not asked to visit a 
participating network community pharmacist.      
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Outcomes 
Medication adherence, as measured by the Proportion of Days 
Covered (PDC), was calculated over a six-month time period 
following hospital discharge by dividing the total days supply 
dispensed by 180 days.20  Chronic scheduled medications used 
to measure adherence included those used for the treatment  
of cardiovascular or pulmonary disease.  Patient pharmacies 
were contacted to obtain information related to medication 
refills that was used to calculate adherence.  Adherence was 
calculated for patients in the intervention group regardless of 
whether they met with the community pharmacist or not.  The 
Wilcoxon rank sum test was used to assess differences 
between groups for the calculated average PDC.  Readmissions 
for any cause were assessed for six months following hospital 
discharge using hospital electronic health records.  Medication 
discrepancies were defined as any correction or clarification 
made to the previously completed admission medication 
reconciliation.  Actual or potential medication-related 
problems identified by the hospital pharmacist were 
quantified and categorized using a classification tool and 
included recommendations related to medication monitoring, 
suboptimal drug or regimen prescribed, disease state under 
treatment, need for patient education, and medication non-
adherence.21  Data related to patient interactions and 
interventions involving the network pharmacists were 
documented and collected.  At the completion of the study, a 
qualitative pharmacist survey was completed during an oral 
interview between the primary investigator and network 
community pharmacists.     
 
Results 
Three hundred eighty-seven patients were screened for the 
study.  Of these, 137 were excluded because of permanent or 
planned residence in a long-term care facility; 41 were 
excluded for cognitive impairment; and 29 were excluded 
because of elective surgery, hospice, or non-English speaking 
patients.  Of the 180 eligible patients, 111 declined to 
participate.  Of the 69 patients enrolled, 35 were in the 
intervention group, and 34 were in the control group.   
 
The baseline characteristics were similar between the two 
groups (Table 1).  There was no difference in adherence 
following hospital discharge between the groups (PDC 0.76 
treatment group vs. 0.73 control group, p=0.69; Table 2).  Forty 
three percent of patients in the intervention group were 
readmitted to the hospital within six months compared to 62% 
in the control group.  During verification of the admission 
medication reconciliation, the hospital pharmacist identified 
an average of 5.5 medication discrepancies per patient. 
Discrepancies were categorized and quantified as follows:  
change or clarification of dose, frequency, or formulation 
(31%); patient not taking medication (11%); medication 
omission (34%); add over-the counter medications (6%); and 
clarify allergy (8%).  Nearly half (47%) of the medication 
discrepancies involved a cardiovascular (19%), pulmonary 
(17%), or psychiatric medication (11%).   In the intervention 
group, 206 medication-related problems (mean six per 
patient) were communicated to the network community 
pharmacists for follow-up.  These were categorized as:  
medication monitoring recommended for assessing efficacy 
and/or safety issues (37%), suboptimal drug prescribed (22%), 
under-treatment (15%), patient education needed (12%), non-
adherence (10%), and suboptimal 
dose/duration/frequency/administration (4%).   
 
Network community pharmacist communication with study 
patients in the treatment group varied.  Of the 35 patients in 
the treatment group, 16 (44%) had at least one interaction 
with the network community pharmacist following hospital 
discharge.  Of these, three patients had one  conversation, four 
patients had two to three conversations, and nine patients had 
four to six conversations over six months.  The network 
community pharmacists unsuccessfully attempted to contact 
11 of 36 (31%) patients in the treatment group (i.e., left 
message, no call back).  Nine patients (25%) in the treatment 
group were never contacted by the network community 
pharmacist after hospital discharge.  Reasons for this lack of 
follow-up included patient death (two patients), or the 
community pharmacist forgot or was too busy.  A pharmacist 
from each network community pharmacy was interviewed and 
the themes of this qualitative assessment are discussed below.   
 
Discussion 
This pharmacy model fills a gap in care that is focused on 
providing comprehensive medication management through 
collaboration between the patient’s healthcare providers.  Our 
goals for this study were to assess the feasibility of this 
innovative clinical model and determine if adherence was 
improved.  We found no significant difference between the 
two groups with medication adherence, largely due to a 
higher-than expected baseline adherence   based on previous 
evidence that approximately half of medications for chronic 
disease are not taken as prescribed.5,6   This study was highly 
informative in assessing the feasibility of the clinical model 
which will be divided into three factors involving the hospital 
pharmacist, community pharmacist, and patient. 
 
The conversation between the hospital pharmacist and patient 
is a crucial step in completing a comprehensive medication 
review and  considering opportunities for improved 
medication management that is consistent with the patient’s 
goals and preferences (i.e., patient-centered).  A medication 
expert can ask follow-up questions based on the patient’s 
verbal and nonverbal responses to probe for additional 
information.  Through this process, not only are discrepancies 
in the admission home medication list identified, but an 
accurate medication list can then be used to identify 
medication-related problems, assess the appropriateness of 
medication management, and consider opportunities for 
improvement.   Interestingly, the pharmacist identified an 
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average of 5.5 discrepancies in the home medication list after 
an admission medication reconciliation had already been 
completed by a nurse or physician, highlighting errors in the 
medication reconciliation process and the possibility of leading 
to medication errors during hospitalization and at discharge.  
While many medication-related problems were identified and 
resolved during hospitalization, an average of 6 actual or 
potential problems per patient were communicated to the 
network community pharmacist for follow-up.  Overall, we 
believe that the investment in a hospital pharmacist’s time to 
devote to medication reconciliation and a comprehensive 
medication review that includes a conversation with the 
patient is an effective way to provide patient-centered care, 
prevent medication-related problems and improve medication 
safety.   
 
The role of the network community pharmacists is highly 
dependent on their work-flow and other responsibilities.  For 
the sixteen patients who had at least one interaction with the 
network pharmacist, several important medication-related 
topics were addressed.  Most pharmacists discussed an 
overview of the medication list and why each medication was 
prescribed.  Pharmacists also encouraged patients to talk with 
their physicians about important issues such as blood glucose 
control, the need for acid-suppressing medications, and 
options for less expensive medications.  One pharmacist 
worked with a care manager to arrange for the patient to 
obtain samples of maintenance inhalers, leading to improved 
adherence and reduced use of a rescue inhaler.  Patient 
education was provided on topics such as patient assistance 
programs, the importance of inhalers, recommended use of 
maintenance and rescue inhalers, smoking cessation, warfarin 
education, medications that increase fall risk, and the benefits 
and risks of calcium and vitamin D supplementation.  The 
network community pharmacists also contacted the primary 
care physicians when needed to resolve medication related 
problems.  When a long-acting maintenance inhaler was 
inadvertently discontinued during hospital discharge, the 
pharmacist intervened to get it resumed.  A pharmacist also 
called a primary care physician to discuss reducing the dose of 
aspirin from 325mg to 81mg and adding a statin for secondary 
cardiovascular prevention.  These examples illustrate how 
collaboration between hospital pharmacists, community 
pharmacists, and physicians can prevent medication-related 
problems throughout care transitions. 
 
Several themes emerged from the qualitative survey of the 
community pharmacists.  The pharmacists stressed that it was 
easier to engage patients if they were an existing customer of 
the pharmacy.  Sometimes the pharmacists felt intrusive when 
contacting a patient that was not their existing customer. 
Having an established relationship can help both the 
pharmacist and patient feel more comfortable discussing 
health-related information.  Another advantage for working 
with their own patients is having more information about the 
patient’s prescribed medications and refill history to assess 
adherence.    
 
Most pharmacists agreed that participating in the study helped 
improve their clinical skills specifically with medication therapy 
management and patient education. They appreciated the 
medication information faxed from the hospital pharmacist 
because it was helpful knowing how to start the conversation 
with the patient and how to prioritize medication related 
problems.  They suggested regular reminders from the study 
investigator to remember to follow-up with patients. 
Telephonic communication was acceptable, but most agreed 
that seeing the patient in person is better in developing a 
rapport and facilitating open communication. 
 
One hundred eleven eligible patients declined to participate 
with the most common reason being talking to a different 
pharmacist.  Patients who had an existing relationship with 
their community pharmacist were frequently not interested in 
meeting with an additional pharmacist.  Another reason for 
declining to participate was the patient’s perception of a lack 
of benefit from talking with a pharmacist, elucidating an 
opportunity to educate patients about how talking with 
pharmacists can improve their health.  Other patients found 
the study process to be inconvenient and did not want an 
additional appointment, find additional transportation for the 
appointment, and/or burden their caregivers to arrange an 
appointment.  Lastly, several patients were reluctant to 
participate in a research study.  
 
To overcome these barriers, an ongoing modified version of 
this study model is focused on the communication between 
the hospital pharmacist and the patient’s existing community 
pharmacist, regardless of whether they are a network 
community pharmacist or not.  We have also expanded our 
inclusion criteria to identify additional patients at increased 
risk of medication-related problems and hospital 
readmissions.  Likewise, we have expanded our outreach to 
community pharmacists and primary care physicians to 
identify opportunities to collaborate on patient care activities 
during care transitions.   
 
While other studies of various interventions have 
demonstrated a reduction in 30-day hospital readmissions, 
they do not insure a comprehensive medication review 
throughout care transitions.11-15  Our approach can potentially 
fill a gap by facilitating collaboration between hospital 
pharmacists, community pharmacists, and physicians to 
provide comprehensive medication management as patients 
transition from hospital to home.  This approach could lead to 
a reduction in medication-related hospitalizations and errors.    
  
Limitations 
This pilot study is limited by a small sample size, although the 
size was sufficient to assess feasibility of the model.  Other 
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limitations include slow patient recruitment, inconsistent 
follow-up by the network community pharmacists, and a 
limited network of community pharmacists. The inconsistent 
follow-up by the network community pharmacists created a 
further limitation in interpreting the impact of the pharmacy 
practice model on medication adherence as it was calculated 
for patients in the intervention group regardless of whether 
they met with the community pharmacist or not.  Another 
confounding variable is the possibility that patients received 
medication therapy management from other sources 
unrelated to this study, which could have influenced 
medication adherence.  Additionally, readmissions were 
determined using the study hospital site, so readmissions to 
other hospitals were not included.   
 
Conclusion 
The quality of health care during care transitions has 
significant room for improvement and community pharmacists 
are uniquely positioned to collaborate with other healthcare 
providers to provide patient-centered care and improve 
medication management.  Pharmacists can improve the 
transition of care by preventing medication-related problems, 
encouraging the appropriate use of medications, and 
facilitating communication with other healthcare providers.  
Pharmacists can educate patients about their medications, 
lifestyle modifications, appropriate self-care, and disease state 
management.  This can only happen, however if the 
community pharmacists have current and accurate 
information about their patients such as an accurate 
medication list, medication indications, and reasons for 
medication changes at hospital discharge.  In addition, this 
process needs to be integrated into the pharmacist workflow 
in both the hospital and community settings.  We believe that 
collaboration between the hospital and community 
pharmacist can improve medication management in patients 
at increased risk for medication-related problems.  This 
approach would facilitate comprehensive medication 
management across care transitions. 
 
Funding: Community Pharmacy Foundation 
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Table 1:  Baseline Characteristics 
 Treatment (35) Control (34) 
Age (years) 64 69 
Male Gender 16 (46%) 15 (44%) 
Education level (graduated from HS) 26 (74%) 27 (79%) 
Prior Hospitalization within 1 year 19(54%) 21 (62%) 
RealmR scorea 6.6 5.7 
aThe Rapid Estimate of Adult Literacy in Medicine-Revised is a rapid assessment of potential health literacy problems.   





Table 2:  Study Outcomes 
 Treatment Group 
(N=35) 
Control Group (N=34) p-value 
Adherence (PDC > 80%) 0.76 0.73 0.69 
Patients with readmissions within 6 months 
(yes/no) 
15/36 (43%) 21/34 (62%) NA 
 
 
 
 
 
 
